BFC Planning’s Genetic Technologies GENE Stock Holding History
Bought
Maintained
Sold
Other funds holding GENE
BFC Planning's GENE Position: Q4 2024 in Review
BFC Planning sold out of Genetic Technologies (GENE) in Q4 2024, closing a stake of 200 shares — an estimated $155 sold.
BFC Planning first reported a position in GENE in Q3 2024 and held it in 1 quarter. The position peaked at $155 in Q3 2024. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.
- BFC Planning reported no remaining Genetic Technologies position as of Q4 2024 after selling out during the quarter.
- BFC Planning sold 200 Genetic Technologies shares in Q4 2024, an estimated $155.
- BFC Planning first reported a position in Genetic Technologies in Q3 2024 and held it in 1 quarter.
- BFC Planning's Genetic Technologies position peaked at $155 in Q3 2024.
- 1 fund tracked by Wall St. Rank held Genetic Technologies as of Q4 2024.
Based on BFC Planning's 13F filing for Q4 2024, filed 29 Oct 2026.